Spots Global Cancer Trial Database for leukemia, lymphocytic, acute
Every month we try and update this database with for leukemia, lymphocytic, acute cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Functional Pharmacogenomics of Childhood Acute Lymphoblastic Leukemia in Taiwan | NCT00526084 | Leukemia, Lymph... | 1 Year - 18 Years | National Taiwan University Hospital | ||
| T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis | NCT01078337 | Leukemia, Lymph... | bone marrow asp... peripheral bloo... | - 18 Years | Stanford University | |
| Randomized Double Cord Blood Transplant Study | NCT00067002 | Leukemia, Lymph... Leukemia, Myelo... Leukemia, Myelo... Lymphoma, Non-H... | Expanded alloge... One Unmanipulat... Rituxan Melphalan Thiotepa Fludarabine Cyclophosphamid... Mesna Total body irra... | 1 Month - 80 Years | M.D. Anderson Cancer Center | |
| Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML) | NCT00185523 | Leukemia, Lymph... Leukemia Leukemia Acute ... Leukemia Acute ... Leukemia Chroni... Leukemia Acute ... Leukemia Chroni... | Allogeneic hema... | 4 Weeks - 55 Years | Stanford University | |
| Stem Cell Transplantation for Hematological Malignancies | NCT00176839 | Leukemia, Lymph... AML MDS | Stem Cell Trans... Busulfan Cyclophosphamid... Melphalan G-CSF ATG | - 35 Years | Masonic Cancer Center, University of Minnesota | |
| Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies | NCT00038883 | Leukemia, Lymph... Leukemia, Lymph... Lymphoma, Low-G... Lymphoma, T-Cel... Lymphoma, B-Cel... | Campath-1H | 15 Years - 60 Years | M.D. Anderson Cancer Center | |
| Adult ALL Treatment at Diagnosis | NCT00537550 | Leukemia, Lymph... | Vincristine Vincristin, Dau... | 14 Years - 60 Years | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-progenitor Acute Lymphoblastic Leukemia | NCT00313053 | Leukemia, Lymph... Leukemia Acute Lymphoid ... | Human mAb 216 Vincristine | 12 Months - 18 Years | Stanford University | |
| Stem Cell Transplantation for Hematological Malignancies | NCT00176839 | Leukemia, Lymph... AML MDS | Stem Cell Trans... Busulfan Cyclophosphamid... Melphalan G-CSF ATG | - 35 Years | Masonic Cancer Center, University of Minnesota | |
| Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402) | NCT00406393 | Leukemia, Myelo... Leukemia, Lymph... Leukemia, Myelo... Myelodysplastic... | Tacrolimus Methotrexate Sirolimus | 2 Years - 60 Years | Medical College of Wisconsin | |
| Stem Cell Transplantation for Hematological Malignancies | NCT00176839 | Leukemia, Lymph... AML MDS | Stem Cell Trans... Busulfan Cyclophosphamid... Melphalan G-CSF ATG | - 35 Years | Masonic Cancer Center, University of Minnesota | |
| Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia | NCT00167167 | Leukemia, Myelo... AML MDS Leukemia, Lymph... | Donor Lymphocyt... | 1 Year - 60 Years | Masonic Cancer Center, University of Minnesota | |
| Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy | NCT05154474 | Metastatic Canc... Cancer, Breast Cancer Colon Cancer, Rectum Cancer, Lung Cancer Ovaries Cancer Prostate Cancer, Kidney Cancer Pancreas Myeloma Myelodysplasia Leukemia, Myelo... Leukemia,Myeloi... Leukemia, Lymph... Leukemia, Lymph... | Standard | 18 Years - | Weprom | |
| CD34+ Transplants for Leukemia and Lymphoma | NCT05565105 | Leukemia, Myelo... Leukemia, Lymph... | Total Body Irra... Thiotepa Cyclophosphamid... Busulfan Melphalan Fludarabine | 18 Years - 74 Years | Baptist Health South Florida | |
| Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies | NCT00246662 | Leukemia, Lymph... Leukemia, Nonly... Leukemia, Myelo... Myelodysplastic... | Vosaroxin | 18 Years - | Sunesis Pharmaceuticals | |
| Functional Pharmacogenomics of Childhood Acute Lymphoblastic Leukemia in Taiwan | NCT00526084 | Leukemia, Lymph... | 1 Year - 18 Years | National Taiwan University Hospital | ||
| Study of SCH 900776 (MK-8776) With and Without Cytarabine in Participants With Acute Leukemias (P05247) | NCT00907517 | Myelogenous Leu... Leukemia, Lymph... Leukemia, Lymph... Myelogenous Leu... | MK-8776 Cytarabine | 18 Years - | Merck Sharp & Dohme LLC | |
| Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors | NCT01100658 | ALL, Childhood Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphocytic Leu... Lymphocytic Leu... Lymphocytic Leu... Brain Tumors Cancer of the B... Cancer of Brain Malignant Prima... Brain Neoplasms... | Methylphenidate Placebo | 8 Years - 17 Years | University of Minnesota | |
| CART-19 FOR Relapsed/Refractory Acute Lymphoblastic Leukemia （ALL） | NCT03544021 | Leukemia, Lymph... | CART-19 cells | 14 Years - 75 Years | The Affiliated Hospital of the Chinese Academy of Military Medical Sciences | |
| Post Transplant Donor Lymphocyte Infusion | NCT00167180 | Leukemia, Myelo... Lymphomas Multiple Myelom... Myelodysplastic... Leukemia, Lymph... Leukemia, Lymph... AML | Donor Lymphocyt... Induction Chemo... | 1 Year - 70 Years | Masonic Cancer Center, University of Minnesota | |
| Allogeneic Transplantation for Patients With Acute Leukemia or Chronic Myelogenous Leukemia (CML) | NCT00185523 | Leukemia, Lymph... Leukemia Leukemia Acute ... Leukemia Acute ... Leukemia Chroni... Leukemia Acute ... Leukemia Chroni... | Allogeneic hema... | 4 Weeks - 55 Years | Stanford University | |
| Adult ALL Treatment at Diagnosis | NCT00537550 | Leukemia, Lymph... | Vincristine Vincristin, Dau... | 14 Years - 60 Years | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation | NCT00698685 | Leukemia Lymphoma Hodgkin's Disea... Hematologic Neo... Multiple Myelom... Carcinoma, Rena... | Pentostatin Alemtuzumab Allogeneic hema... | 18 Years - 75 Years | University of Arizona | |
| High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology | NCT04940468 | Leukemia, Lymph... Leukemia, Myelo... Lymphoma Clostridium Dif... | Diet Interventi... | 9 Years - | University of Colorado, Denver | |
| DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL) | NCT03110354 | Leukemia, Myelo... Leukemia, Lymph... | DS-3201b | 18 Years - | Daiichi Sankyo | |
| High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology | NCT04940468 | Leukemia, Lymph... Leukemia, Myelo... Lymphoma Clostridium Dif... | Diet Interventi... | 9 Years - | University of Colorado, Denver | |
| Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor | NCT00393380 | Leukemia, Myelo... Anemia, Aplasti... Myelofibrosis Lymphoma Hodgkin Disease Leukemia, Lymph... Leukemia, Myelo... Leukemia, Lymph... | Parathyroid Hor... | 18 Years - 45 Years | The Emmes Company, LLC | |
| NOPHO ALL-2008 Pilot Study on Consolidation Therapy for Children and Adolescents With Acute Lymphoblastic Leukemia | NCT00548431 | Leukemia, Lymph... | 6-mercaptopurin... | 1 Year - 18 Years | Rigshospitalet, Denmark | |
| High- Fiber/ Low-fat Diet for Prevention of Recurrent Clostridioides Difficile Infection in Oncology | NCT04940468 | Leukemia, Lymph... Leukemia, Myelo... Lymphoma Clostridium Dif... | Diet Interventi... | 9 Years - | University of Colorado, Denver | |
| Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors | NCT01100658 | ALL, Childhood Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Leukemia, Lymph... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphoblastic L... Lymphocytic Leu... Lymphocytic Leu... Lymphocytic Leu... Brain Tumors Cancer of the B... Cancer of Brain Malignant Prima... Brain Neoplasms... | Methylphenidate Placebo | 8 Years - 17 Years | University of Minnesota | |
| Post Transplant Donor Lymphocyte Infusion | NCT00167180 | Leukemia, Myelo... Lymphomas Multiple Myelom... Myelodysplastic... Leukemia, Lymph... Leukemia, Lymph... AML | Donor Lymphocyt... Induction Chemo... | 1 Year - 70 Years | Masonic Cancer Center, University of Minnesota | |
| Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage | NCT00905034 | Leukemia, Lymph... | Methotrexate Vincristine PEG-l-asparagin... Dexamethasone Rituximab | 1 Year - | M.D. Anderson Cancer Center | |
| Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia | NCT00167167 | Leukemia, Myelo... AML MDS Leukemia, Lymph... | Donor Lymphocyt... | 1 Year - 60 Years | Masonic Cancer Center, University of Minnesota | |
| CD34+ Transplants for Leukemia and Lymphoma | NCT05565105 | Leukemia, Myelo... Leukemia, Lymph... | Total Body Irra... Thiotepa Cyclophosphamid... Busulfan Melphalan Fludarabine | 18 Years - 74 Years | Baptist Health South Florida |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
